Skip to main contentSkip to navigation
Sirius Investors
Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP
NASDAQHealthcare

Revenue Analysis - MEDP

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

MEDP Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Metabolic

0.0% of total revenue

$219.1M

Oncology

0.0% of total revenue

$209.4M

Other

0.0% of total revenue

$98.3M

Central Nervous System

0.0% of total revenue

$82.9M

Cardiology

0.0% of total revenue

$60.0M

Antiviral And Anti Infective

0.0% of total revenue

$37.8M

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Antiviral And Anti Infective
Cardiology
Central Nervous System
Metabolic
Oncology
Other
6/30/2026$37.8M$60.0M$82.9M$219.1M$209.4M$98.3M
3/31/2026$38.0M$56.3M$80.2M$237.6M$201.2M$93.3M
12/31/2025$38.3M$63.0M$73.2M$249.8M$195.9M$88.3M
9/30/2025$36.5M$59.5M$65.6M$199.3M$192.6M$106.4M
6/30/2025$29.1M$58.6M$61.1M$147.9M$188.6M$118.1M
3/31/2025$31.1M$58.3M$54.9M$148.0M$170.5M$95.8M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Stable Segments
Metabolic-7.8%
Oncology+4.0%
Other+5.3%

Earnings Reports

Want to see how MEDP's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports